Literature DB >> 3291906

Benign tumors and pseudotumors of the liver.

K G Ishak1.   

Abstract

The pathologic and clinical aspects of benign tumors and pseudotumors of the liver are reviewed. They are classified according to the tissue of organ into epithelial (further subclassified into tumors of hepatocellular and cholangiocellular origin), mesenchymal or mixed derivation, and a miscellaneous group. Some of the tumors and pseudotumors, e.g. bile duct adenoma, small focal nodular hyperplasias and cavernous hemangiomas, and focal fatty change, are of no clinical significance. Others, such as nodular regenerative hyperplasia, hepatocellular adenoma and giant hemangioma, can be manifested by portal hypertension, hemoperitoneum or a hemorrhagic diathesis respectively. Cognizance of the histopathologic criteria for diagnosis, the radiologic features and the varied clinical manifestations are essential for management. The malignant potential of some of the benign tumors is briefly touched upon.

Entities:  

Mesh:

Year:  1988        PMID: 3291906

Source DB:  PubMed          Journal:  Appl Pathol        ISSN: 0252-1172


  4 in total

Review 1.  Primary leiomyoma of the liver. A case report and review of the literature.

Authors:  T E Reinertson; J B Fortune; J C Peters; I Pagnotta; J A Balint
Journal:  Dig Dis Sci       Date:  1992-04       Impact factor: 3.199

2.  "Pseudo-pseudotumor" of the liver. Adenocarcinoma presenting as an inflammatory pseudotumor.

Authors:  R E Schwarz; J C Reynolds; M T Lotze
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

3.  Modified full-field optical coherence tomography: A novel tool for rapid histology of tissues.

Authors:  Manu Jain; Nidhi Shukla; Maryem Manzoor; Sylvie Nadolny; Sushmita Mukherjee
Journal:  J Pathol Inform       Date:  2011-06-14

4.  Large field, high resolution full-field optical coherence tomography: a pre-clinical study of human breast tissue and cancer assessment.

Authors:  Osnath Assayag; Martine Antoine; Brigitte Sigal-Zafrani; Michael Riben; Fabrice Harms; Adriano Burcheri; Kate Grieve; Eugénie Dalimier; Bertrand Le Conte de Poly; Claude Boccara
Journal:  Technol Cancer Res Treat       Date:  2013-08-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.